Current Edition

Pic 2 (1)
Volume 9 Issue 3

A Workplace Revolution – The Digital Workplace in Life Sciences

The way life sciences organisations work and collaborate has changed drastically over the past decade or so. The new digital workplace is thriving and the …

Continue Reading →
Pic 3 (1)
Volume 9 Issue 3

Regulation of Controlled Drug Substances in SAARC Countries

The global illegal drug trade represents a multi-dimensional challenge that has implications in the international community. The South Asian region is the principal trafficking route …

Continue Reading →
Picture 4
Volume 9 Issue 3

Keeping Up with a Shifting Regulatory Landscape

Patient safety is at the forefront of considerations in the pharmaceutical industry, with high expectations from patients and care providers for quality in injectable medicines. …

Continue Reading →
Pic 1 (1)
Volume 9 Issue 3

A Pharmacy’s Role in Antimicrobial Stewardship

Antimicrobial stewardship strategies form a vital filtration system for our healthcare system. Here, Adrian Pittock, Marketing Director of Valley Northern, explains the vital role that …

Continue Reading →
Ghent_VisitFlanders_Copyright Stad Gent
Volume 9 Issue 3

Flanders: The Life Sciences Nucleus of Western Europe

Flanders, a region comprising the northern half of Belgium, might be small in surface area, but it’s home to one of the most vibrant life …

Continue Reading →
PIC 3 (2)
Volume 9 Issue 3

Sensory Analysis of Pharmaceutical Products Using Electronic Tongue and Nose

Pharmaceutical companies must now count taste and smell as new priorities during formulation development, especially for paediatric and geriatric medicines. Commonly, pharmaceutical laboratories have recourse …

Continue Reading →
reducing drug discovery
Volume 9 Issue 3

Reducing Drug Discovery Timelines When Using Mouse Models

With the drug discovery timeline exceptionally long and late-stage failure rates very high, there is tremendous pressure to reduce the discovery timeframe and bring effective …

Continue Reading →
PIC 1 (3)
Volume 9 Issue 3

Using Intelligent Design to Deliver Safe Preservative-free Multidose Eye-drops

A significant patient population requires the long-term use of eye-drops multiple times a day. Maintaining the sterility of eye-drops is important for patient health. Single-use …

Continue Reading →
redefining the art
Volume 9 Issue 3

Redefining the Art of Patient and Stakeholder Engagement in Rare Disease Clinical Research

Because of the rarity, heterogeneity and complex patient management associated with rare conditions, creating a pharmaceutical development programme for the treatment of one of these …

Continue Reading →
PIC 2 (2)
Volume 9 Issue 3

The Future of Clinical Trials

The International Council on Harmonisation has adapted its guidelines to include radical changes to the design, implementation and monitoring of clinical trials. The principles are …

Continue Reading →